Publication | Closed Access

The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion

Cognitive NeuroscienceBehavioral NeuroscienceMedicinePharmacologyPsychopharmacologyNeuropharmacologyPharmacotherapyNeuroscienceReward SystemDopamineExperimental PsychologySocial Sciences